Appetite and Adiposity Across a Continuum of Activity (AAA)

May 3, 2016 updated by: Robin Shook, Iowa State University
The purpose of this study is to understand what happens when someone either becomes more active or more inactive. This study will measure your energy intake, energy expenditure, and body composition under normal conditions, when you become active, and when you become inactive.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and women

    • Age 25-35 yrs
    • BMI ≥25.0 to <35.0 kg/m2
    • Subjective physical activity (pre run-in): Sedentary for the previous 3 months (< 20min, 3 times/week of structured exercise)
    • Objective physical activity (run-in): daily steps/day >4500 yet <7,000 during 7 day run-in period
    • Weight-stable (± 5%) within the previous 3 months
    • Non-smoking for last year
    • Able to provide own transportation to study visits and intervention
    • Not currently involved in any other research study
    • Willing and able to participate in all aspects of the trial including research testing
    • Willing to give informed consent to participate
    • Able to participate in a moderate physical exercise program

Exclusion Criteria:

  • Self-reported significant cardiovascular disease including but not limited to serious arrhythmias, cardiomyopathy, congestive heart failure, myocardial infarction, stroke

    • Other self-reported medical conditions including but not limited to metabolic disorders such as diabetes, chronic or recurrent respiratory conditions, active cancer, musculoskeletal disease interfering with exercise, or any serious medical condition that may affect adherence to the protocol or exercising safely, or be aggravated by exercise
    • Medications known to affect exercise performance or metabolism (e.g. thyroid medication, beta-blockers, or stimulants)
    • Excess caffeine use (> 500mg/day)
    • Restrained eater (>13) on the restraint section of the three-factor eating questionnaire
    • Current or past diagnosis of an eating disorder
    • Any self-reported contraindications to exercise according to the American College of Sports Medicine criteria
    • Pregnant or actively trying to become pregnant
    • Gave birth in the past 12 months or <6 months post-lactation
    • Other medical, psychiatric or behavioral factors that in the judgment of the principal investigator may interfere with study participation or the ability to follow the intervention protocol.
    • Known allergy to the metal nickel
    • Known allergies to pasta or tomato sauce

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sedentary
Individuals will reduce their physical activity level for 14-days
Participants will self-monitor their physical activity level via activity monitors
Experimental: Active
Individuals will increase their physical activity level for 14-days
Participants will self-monitor their physical activity level via activity monitors

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Appetite- subjective
Time Frame: 14 days
Change in appetite will be assessed through subjective ratings of hunger and fullness
14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Appetite- objective
Time Frame: 14 days
Change in appetite will be assessed through objective measures of appetite-related hormones
14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (Anticipated)

October 1, 2017

Study Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

April 4, 2016

First Submitted That Met QC Criteria

May 3, 2016

First Posted (Estimate)

May 5, 2016

Study Record Updates

Last Update Posted (Estimate)

May 5, 2016

Last Update Submitted That Met QC Criteria

May 3, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • AAA-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity and Sedentary Behavior

Clinical Trials on Self-monitoing

Subscribe